PlainPharmaWatch

CMS Open Payments · Program Year 2024

Michigan

Michigan received $101,805,300.73 in pharmaceutical-industry payments to 24,117 physicians and 54 teaching hospitals across 487,037 transactions.

$101.8M
Total payments
$60.2M
To physicians
$34.5M
To teaching hospitals
#11
of 59 states

In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $101.8M in payments to 24,117 physicians and 54 teaching hospitals in Michigan. That ranks Michigan #11 of 59 states and territories (0.7% of the US total), averaging $2.5K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

The verdict

Michigan pairs top-quartile payment volume with a balanced mix between physicians and hospitals.

#11
of 59 states
0.7%
of the national total
59.1%
to physicians vs. hospitals
24,117
physicians paid

What the Data Shows for Michigan

Michigan's Open Payments file is hospital-weighted: 33.9% of $101.8M went to 54 teaching hospitals ($639.8K each), with 59.1% on 24,117 physicians.

On the national dollar ranking it is still #11 of 59 (0.7% of US payments). Average transaction $209.03. Leading nature of payment: "Royalty or License" at $32.2M (31.6% of the state file; top-three natures 66.5%).

Michigan sits in the 83rd percentile (mid-pack). Just above: Georgia ($107.1M). Just below: North Carolina ($97.2M). For context: top-ranked California ($342.4M) is 3.4× larger than Michigan. CMS Sunshine Act framework and methodology.

Physician vs Hospital Payments

How pharmaceutical payments in Michigan are distributed between physicians and teaching hospitals.

Physician Payments

$60.2M

59.1% of total · 24,117 recipients · $2.5K avg

Teaching Hospital Payments

$34.5M

33.9% of total · 54 hospitals · $639.8K avg

Payment Breakdown by Type

Michigan has 16 types of pharmaceutical payments. "Royalty or License" accounts for 31.6%.

Nature concentration in Michigan

Top three Open Payments natures are 66.5% of state dollars; residual is every other reported nature

Royalty or License$32.2MCompensation for Services Ot…$20.6MConsulting Fee$14.8MAll other natures (13)$34.1M

Payment categories in Michigan

Top categories by total reported dollar volume

1. Royalty or License$32.2M2. Compensation for Services…$20.6M3. Consulting Fee$14.8M4. Food and Beverage$12.8M5. Travel and Lodging$6.9M6. Grant$4.7M7. Acquisitions$2.1M8. Space Rental or Facility …$1.9M9. Education$1.6M10. Honoraria$1.3M
Payment Type Amount Transactions
Royalty or License $32.2M 363
Compensation for Services Other Than Consulting $20.6M 7,674
Consulting Fee $14.8M 5,722
Food and Beverage $12.8M 443,609
Travel and Lodging $6.9M 20,848
Grant $4.7M 298
Acquisitions $2.1M 6
Space Rental or Facility Fees $1.9M 383
Education $1.6M 5,642
Honoraria $1.3M 457
Compensation for Faculty or Speaker (Medical Education) $956.8K 423
Long-Term Medical Supply or Device Loan $788.1K 501
Debt Forgiveness $666.2K 164
Charitable Contribution $391.7K 16
Gift $126.9K 827
Entertainment $13.4K 104

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024

What Michigan totals can and cannot tell you

The aggregate payment figure for Michigan measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.

Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.

View saved (states)
Download Michigan's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.